Fangzhou’s AI-Powered Supply Chain Platform Recognized in 2026 for Pharmaceutical Distribution Best Practices
GUANGZHOU, China, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of...
GUANGZHOU, China, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of...
70% in vivo editing of human APOC3 in a single administration76% triglyceride reduction after a single dose in murine disease...
ICHOM Accreditation ICHOM Accreditation RIYADH, Saudi Arabia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre...
PALO ALTO, CA / ACCESS Newswire / October 27, 2026 / Bioz, Inc., a scientific intelligence platform that uses citation...
PS-003 is designed to address the underlying genetic cause of X-linked Alport Syndrome (XLAS), and new preclinical data demonstrate the restoration...